A 13-bp deletion in αIIb gene is a founder mutation that predominates in Palestinian-Arab patients with Glanzmann thrombasthenia

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 12, 2005, Pages 2764-2772

  Rosenberg, N ^a   Hauschner, H ^a   Peretz, H ^b   Mor Cohen, R ^a   Landau, M ^a   Shenkman, B ^a   Kenet, G ^a   Coller, B S ^c   Awidi, A A ^d   Seligsohn, U ^a,e  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c ROCKEFELLER UNIVERSITY   (United States)

^d Rawhi Medical Center   (Jordan)

^e SHEBA MEDICAL CENTER   (Israel)

Author keywords

Founder effect; Integrin IIb 3; Variant Glanzmann thrombasthenia

Indexed keywords

ALPHA2 INTEGRIN; BETA3 INTEGRIN; COMPLEMENTARY DNA; FIBRINOGEN;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARAB; ARTICLE; CHILD; CHROMOSOME DELETION; CLINICAL ARTICLE; FEMALE; FOUNDER EFFECT; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; GLANZMANN DISEASE; HAMSTER; HAPLOTYPE; HUMAN; KIDNEY CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING;

AMINO ACID SUBSTITUTION; ANIMALS; ARABS; BASE SEQUENCE; CELL LINE; CRICETINAE; DNA MUTATIONAL ANALYSIS; EPIDEMIOLOGY, MOLECULAR; FIBRINOGEN; FOUNDER EFFECT; HAPLOTYPES; HUMANS; INTEGRIN BETA3; JORDAN; PLATELET MEMBRANE GLYCOPROTEIN IIB; SEQUENCE DELETION; THROMBASTHENIA; TRANSDUCTION, GENETIC;

EID: 29244480006     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01618.x     Document Type: Article

References (30)

1. Seligsohn U, Rososhansky S. A Glanzmann's thrombasthenia cluster among Iraqi Jews in Israel. Thromb Haemost 1984; 52: 230-1.
2. Khanduri U, Pulimood R, Sudarsanam A, Carman RH, Jadhav M, Pereira S. Glanzmann's thrombasthenia. A review and report of 42 cases from South India. Thromb Haemost 1981; 46: 717-21.
3. Schlegel N, Gayet O, Morel-Kopp MC, Wyler B, Hurtaud-Roux MF, Kaplan C, McGregor J. The molecular genetic basis of Glanzmann's thrombasthenia in a Gypsy population in France: identification of a new mutation on the alpha IIb gene. Blood 1995; 86: 977-82.
4. Awidi AS. Rare inheritaed bleeding disorders secondary to coagulation factors in Jordan: A nine-year study. Acta Haematol 1992; 88: 11-3.
5. Newman PJ, Seligsohn U, Lyman S, Coller BS. The molecular basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. Proc Natl Acad Sci USA 1991; 88: 3160-4.
6. Ahmed MA, Al-Sohaibani MO, Al-Mohaya SA, Sumer T, Al-Sheikh EH, Knox-Macaulay H. Inhibited bleeding disorders in eastern province of Saudi Arabia. Acta Haematol 1988; 79: 202-6.
7. 3) is a second mutation in Iraqi Jews that stemmed from a distinct founder. Blood 1997; 89: 3654-62.
8. Nurden AT, Nurden P. Rebuttal: the French Gypsy mutation does not give rise to a particularly mild form of Glazmann's thrombasthenia. J Thromb Haemost 2003; 1: 2459 (Letter).
9. Xiong J-P, Stehle T, Diefenbach B, Zhang R, Dunker R, Scott DL, Joachimiak A, Goodman SL, Arnaout MA. Crystal structure of the extracellular segment of integrin αVβ3. Science 2001; 294: 339-45.
10. Xiao T, Takagi J, Coller BS, Wang JH, Springer TA. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 2004; 432: 59-67.
11. Dardik R, Kaufman Y, Savion N, Rosenberg N, Shenkman B, Varon D. Platelets mediate tumor cell adhesion to subendothelium under flow conditions: Involvement of platelets GPIIb-IIIa and tumor cell αv integrins. Int J Cancer 1997; 70: 201-7.
12. Rosenberg N, Dardik R, Rosenthal E, Zivelin A, Seligsohn U. Mutations in the αIIb and β3 genes that cause Glanzmann thrombasthenia can be distinguished by a simple procedure using transformed B-lymphocytes. Thromb Haemost 1998; 79: 244-8.
13. Peretz H, Seligsohn U, Zwang E, Coller BS, Newman PJ. Detection of the Glanzmann's thrombasthenia mutations in Arab and Iraqi-Jewish patients by polymerase chain reaction and restriction analysis of blood or urine samples. Thromb Haemost 1991; 66: 500-4.
14. Yatuv R, Rosenberg N, Dardik R, Brenner B, Seligsohn U. Glanzmann thrombasthenia in two Iraqi-Jewish siblings is caused by a novel splice junction mutation in the glycoprotein IIb. Blood Coag Fibrin 1998; 9: 285-98.
15. Jin Y, Dietz HC, Nurden A, Bray PF. Single-strand conformation polymorphism analysis is a rapid and effective method for the identification of mutations and polymorphisms in the gene for glycoprotein IIIa. Blood 1993; 82: 2281-8.
16. French DL, Coller BS, Usher S, Berkowitz R, Eng C, Seligsohn U, Peretz H. Prenatal diagnosis of Glanzmann thrombasthenia using the polymorphic markers BRCA1 and THRA1 on chromosome 17. Br J Haematol 1998; 102: 582-7.
17. Coller BS, Cheresh DA, Asch E, Seligsohn U. Platelet vitronectin receptor expression differentiates Iraqi-Jews from Arab patients with Glanzmann thrombasthenia in Israel. Blood 1991; 77: 75-83.
18. Risch N, de Leon D, Ozelius L, Kramer P, Almasy L, Singer B, Fahn S, Breakefield X, Bressman S. Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population. Nat Genet 1995; 9: 152-9.
19. Reeve JP, Rannala B. DMLE+: Bayesian linkage disequilibrium gene mapping. Bioinformatics 2002; 18: 894-5.
20. Rannala B, Bertorelle G. Using linkage markers to infer the age of a mutation. Hum Mut 2001; 18: 87-100.
21. Rosenberg N, Landau M, Luboshitz J, Rechavi G, Seligsohn U. A novel Phe171Cys mutation in integrin αIIb causes Glanzmann thrombasthenia by abrogating αIIbβ3 complex formation. J Thromb Heamost 2004; 2: 1167-75.
22. Vinciguerra C, Bordet JC, Beaune G, Grenier C, Dechavanne M, Negrier C. Description of 10 new mutations in platelet glycoprotein IIb (αIIb) and glycoprotein IIIa (β3) genes. Platelets 2001; 12: 486-95.
23. Kamata T, Tieu KK, Irie A, Springer TA, Takada Y. Amino acid residues in the alpha IIb subunit that are critical for ligand binding to integrin alpha IIb beta 3 are clustered in the beta-propeller model. J Biol Chem 2001; 276: 44275-83.
24. Tamura T, Hato T, Yamanouchi J, Fujita S. Critical residues for ligand binding in blade 2 of the propeller domain of the integrin alpha IIb subunit. Thromb Haemost 2004; 91: 111-8.
25. Yatuv R, Rosenberg N, Zivelin A, Peretz H, Trakhtenbrot L, Seligsohn U. Identification of a region in glycoprotein IIIa involved in subunit association with glycoprotein IIb: farther lessons from Iraqi-Jewish Glanzmann thrombasthenia. Blood 2001; 98: 1063-9.
26. Krawczak M, Reiss J, Cooper DN. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 1992; 90: 41-54.
27. Claderwood DA. Talin controls integrin activation. Biochem Soc Trans 2004; 32: 434-7.
28. 3 complex. J Clin Invest 1997; 100: 2393-403.
29. O'Toole TE, Ylanne J, Culley BM. Regulation of integrin affinity states through an NPXY motif in the beta subunit cytoplasmic domain. J Biol Chem 1995; 270: 8553-8.
30. 3 (glycoprotein IIb-IIIa) in a variant Glanzmann thrombasthenia. Proc Natl Acad Sci USA 1992; 89: 10169-73.